- Raised $15.5M funding round, Jul 2022
- Raised $12M funding round led by Carl Zeiss, Jul 2022
- Raised $10M funding round, Sep 2017
About
Precise Bio is a regenerative medicine company advancing the use of bio-printed tissues and organs in ophthalmology patients. The company is also building a broad portfolio of R&D programs in additional medical disciplines. The company's commercial and R&D programs are based on its 4D bio-fabrication technology. This platform comprises cell expansion, biomaterials, processes, printing technology, and other technologies. The company's technology platform allows it to advance its fabricated human cornea program concurrent with the development of other organs and tissues for use in ophthalmic indications. Moreover, the company's technology overcomes multiple challenges in scalable, reproducible manufacturing of bio-printed tissues and organs. The company maintains offices, laboratories, and production facilities in North Carolina, United States, and Shoham, Israel.
Funding history · 4 rounds · $22.0M total
Q&A
- What is Precise Bio's primary focus?
- Precise Bio is a regenerative medicine company that advances the use of bio-printed tissues and organs, particularly for ophthalmology patients. The company is also developing R&D programs in other medical disciplines.
- When was Precise Bio founded?
- Precise Bio was founded in July 2015.
- What is Precise Bio's total funding to date?
- Precise Bio has raised a total of $22 million USD.
- Which investors participated in Precise Bio's July 2022 funding round?
- In July 2022, Precise Bio received funding from Carl Zeiss and K20 Fund.
- What is the employee count for Precise Bio?
- Precise Bio has 11-50 employees.
- Where are Precise Bio's main offices and facilities located?
- Precise Bio maintains offices, laboratories, and production facilities in Winston-Salem, North Carolina, United States, and Modi'in-Maccabim-Re'ut, Israel.
- What technology platform does Precise Bio utilize?
- Precise Bio's commercial and R&D programs are based on its 4D bio-fabrication technology, which includes cell expansion, biomaterials, processes, and printing technology.
- Who are the co-founders of Precise Bio?
- The co-founders of Precise Bio are Aryeh Batt (CEO), Anthony Atala (CMO), and Shay Soker (CSO).
Team · 3
Sectors & technology
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | precise-bio.com |
|---|---|
| linkedin.com/company/10439616 | |
| YouTube | youtube.com/channel/UCTF-I1siiWbwvz3YUbO_Umg |
Identifiers & details
| Founded | 2015-7 |
|---|---|
| Employees (exact) | 42 |
| Offices | Winston-Salem |
Radar intelligence
Patents
| EPO | 18 |
|---|
Web history (Wayback)
| Domain | precise-bio.com |
|---|
Certificate / subdomain footprint
| Subdomains | 1 |
|---|